VIROPHARMA Trademark

Trademark Overview

On Friday, September 24, 2021, a trademark application was filed for VIROPHARMA with the United States Patent and Trademark Office. The USPTO has given the VIROPHARMA trademark a serial number of 97043926. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, July 19, 2024. This trademark is owned by ViroPharma Biologics LLC. The VIROPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, antiviral biologics and preparations
viropharma

General Information

Serial Number97043926
Word MarkVIROPHARMA
Filing DateFriday, September 24, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateFriday, July 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, antiviral biologics and preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameViroPharma Biologics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLexington, MA 02421
Party NameViroPharma Biologics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Tuesday, September 28, 2021NEW APPLICATION ENTERED
Tuesday, October 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, June 26, 2022ASSIGNED TO EXAMINER
Wednesday, July 13, 2022NON-FINAL ACTION WRITTEN
Wednesday, July 13, 2022NON-FINAL ACTION E-MAILED
Wednesday, July 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, February 11, 2023NON-FINAL ACTION WRITTEN
Saturday, February 11, 2023NON-FINAL ACTION E-MAILED
Saturday, February 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 30, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 30, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, May 30, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 30, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, June 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 19, 2024SOU TEAS EXTENSION RECEIVED
Friday, July 19, 2024SOU EXTENSION 2 FILED
Friday, July 19, 2024SOU EXTENSION 2 GRANTED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 16, 2024SOU EXTENSION 1 FILED
Tuesday, January 16, 2024SOU EXTENSION 1 GRANTED

Related Keywords

viropharma preparations biologics antiviral namely pharmaceutical